Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data: An Initiative by the Korean Adrenal Disorder Study (KADS) Group

NCT06229405 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06229405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06229405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data: An Initiative by the Korean Adrenal Disorder Study (KADS) Group
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 10, 2022
Completion date
December 31, 2024
Enrollment
8,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal cortical carcinoma, adrenal tumor, cushing syndrome, pheochromocytoma, primary aldosteronism